Skip to main content
. 2015 Jun 9;4(1):49–54. doi: 10.1177/2050640615590303

Table 2.

Rebleeding and mortality of APC and control patients, grouped according to ECOG performance status

Re-bleeding p mortality p
Group I 0.412 0.669
APC 6/18 (33%) 3/18 (17%)
Control 3/17 (18%) 6/17 (35%)
Group II 0.505 0.580
APC 2/6 (33%) 2/6 (33%)
Control 1/11 (9%) 6/11 (55%)

APC: argon plasma coagulation; ECOG: Eastern Cooperative Oncology Group score; Group I: good performance status (ECOG 0–2); Group II: poor performance status (ECOG 3–4).